High-Dose Vitamin C Doubles Pancreatic Cancer Patient Survival Rates: Clinical Trial
By Cara Michelle Miller Adding high-dose vitamin C to a cancer treatment regimen may double survival time, according to a clinical trial that tested this in pancreatic cancer patients. Typically diagnosed in its advanced stages, pancreatic cancer has a poor prognosis and leaves patients with limited treatment options, with most surviving only eight months with standard chemotherapy.
More Stories
EV Biologics (OTCMKTS:YECO) Shares Up 16.7% – Here’s Why
EV Biologics, Inc. (OTCMKTS:YECO – Get Free Report) shot up 16.7% on Tuesday . The company traded as high as...
Virgin Group Acquisition Corp. II (NYSE:VGII) Shares Down 0.7% – Here’s What Happened
Virgin Group Acquisition Corp. II (NYSE:VGII – Get Free Report)’s stock price was down 0.7% during trading on Tuesday ....
SciSparc (NASDAQ:SPRC) Shares Up 5.7% – Here’s What Happened
SciSparc Ltd. (NASDAQ:SPRC – Get Free Report)’s share price was up 5.7% during mid-day trading on Tuesday . The stock...
Unrivaled Brands (OTCMKTS:UNRV) Stock Price Up 31.3% – Here’s What Happened
Unrivaled Brands, Inc. (OTCMKTS:UNRV – Get Free Report)’s stock price shot up 31.3% during mid-day trading on Tuesday . The...
Innodata Inc. (NASDAQ:INOD) COO Ashok Mishra Sells 69,218 Shares
Innodata Inc. (NASDAQ:INOD – Get Free Report) COO Ashok Mishra sold 69,218 shares of the firm’s stock in a transaction...
Avon Protection (OTCMKTS:AVNBF) Trading 8.7% Higher – Should You Buy?
Avon Protection plc (OTCMKTS:AVNBF – Get Free Report) shares were up 8.7% during trading on Tuesday . The stock traded...